Actavis
Actavis[edit | edit source]
Actavis plc was a global pharmaceutical company that, after a series of mergers, became a part of the current company Allergan plc.
Overview[edit | edit source]
Originally based in Iceland, Actavis grew rapidly through both organic growth and acquisitions, eventually becoming one of the largest generic pharmaceutical companies in the world.
History[edit | edit source]
- 1956: Actavis was founded in Iceland as Pharmaco.
- 1999: The company was renamed Actavis following a merger.
- 2000s: Actavis experienced rapid growth and expansion, completing numerous acquisitions globally.
- 2015: Actavis completed the acquisition of Allergan, Inc., a transformative deal. Post-acquisition, the combined company adopted the name Allergan plc.
Notable Acquisitions[edit | edit source]
- Warner Chilcott: In 2013, Actavis acquired the specialty pharmaceutical company, enhancing its branded drug portfolio.
- Forest Laboratories: Acquired in 2014, this deal significantly expanded Actavis' branded drug business.
Key Products[edit | edit source]
Actavis had a vast product range that covered various therapeutic areas. Some of the most notable include:
- Generic formulations of blockbuster drugs.
- Specialty brand pharmaceuticals in areas such as women’s health, gastroenterology, and dermatology.
Facilities[edit | edit source]
Actavis had manufacturing, R&D, and commercial operations worldwide. Its facilities adhered to global quality standards and catered to both domestic and international markets.
Corporate Culture[edit | edit source]
Actavis was known for its dynamic culture, emphasizing innovation, growth, and a commitment to delivering high-quality pharmaceuticals to patients globally.
Controversies[edit | edit source]
The rapid growth of Actavis and its aggressive acquisition strategy did lead to certain criticisms, especially around issues of drug pricing and antitrust concerns.
See Also[edit | edit source]
References[edit | edit source]
- [1] "Actavis: Company History". Actavis Corporate Archive.
- [2] "Actavis and the Landscape of Generic Pharmaceuticals". Pharmaceutical Journal.
- [3] "Actavis Completes Allergan Acquisition". Financial Times.
 | This corporation or company article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
